Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers

Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers

Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in liver transplant recipients, but their toxicity needs to be balanced against the benefits. The choice of prevention strategy...

Full description

Bibliographic Details
Main Authors: Cornelius Engelmann, Martina Sterneck, Karl Heinz Weiss, Silke Templin, Steffen Zopf, Gerald Denk, Dennis Eurich, Johann Pratschke, Johannes Weiss, Felix Braun, Martin-Walter Welker, Tim Zimmermann, Petra Knipper, Dirk Nierhoff, Thomas Lorf, Elmar Jäckel, Hans-Michael Hau, Tung Yu Tsui, Aristoteles Perrakis, Hans-Jürgen Schlitt, Kerstin Herzer, Frank Tacke
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Clinical Medicine
Subjects:
OLT
ganciclovir
valganciclovir
mTOR inhibitor
Online Access:https://www.mdpi.com/2077-0383/9/8/2352

Internet

https://www.mdpi.com/2077-0383/9/8/2352

Similar Items